Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BLTE compared with GMAB: revenue, margins and what each company keeps, and the suppliers and customers both name
BLTE
Belite Bio, Inc
Change
Mkt cap
Revenue
Revenue
GMAB
Genmab A/S
Change
Mkt cap
Revenue
Revenue
vs
Compare
BLTE
Belite Bio, Inc
vs
GMAB
Genmab A/S
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BLTE
1
—
The Trustees of Columbia University in the City of New York
unlisted
supplier
Shared
0
No shared counterparties.
Only GMAB
1
COAG
Hemab Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
BLTE
Belite Bio, Inc
Change
153.24
▼
−0.28%
· post 153.23
Mkt cap
$6.0B
GMAB
Genmab A/S
Change
54.93
▲
+0.01%
· post 55.50
Closed
Nov 3 '26
Mkt cap
$35.3B
vs
Compare
Closed
Nov 3 '26
BLTE
Belite Bio, Inc
vs
GMAB
Genmab A/S
153.24
▼
−0.28%
post 153.23
Price
54.93
▲
+0.01%
post 55.50
$6.0B
Mkt cap
$35.3B
Change
Change
BLTE
153.24
▼
−0.28%
vs
GMAB
54.93
▲
+0.01%
Closed
Nov 3 '26